DE60042598D1 - Medikamente zur behandlung des syndroms der chronishen ermüdung, das mit fibromyalgie und reizdarm assoziert ist. - Google Patents
Medikamente zur behandlung des syndroms der chronishen ermüdung, das mit fibromyalgie und reizdarm assoziert ist.Info
- Publication number
- DE60042598D1 DE60042598D1 DE60042598T DE60042598T DE60042598D1 DE 60042598 D1 DE60042598 D1 DE 60042598D1 DE 60042598 T DE60042598 T DE 60042598T DE 60042598 T DE60042598 T DE 60042598T DE 60042598 D1 DE60042598 D1 DE 60042598D1
- Authority
- DE
- Germany
- Prior art keywords
- fibromyalgia
- irritant
- medicaments
- syndrome
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Finger-Pressure Massage (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9924172A GB2355191A (en) | 1999-10-12 | 1999-10-12 | Combination formulations for fatigue, head injury and strokes |
PCT/GB2000/003926 WO2001026623A2 (en) | 1999-10-12 | 2000-10-12 | Treatment of fatigue, head injury and stroke |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60042598D1 true DE60042598D1 (de) | 2009-09-03 |
Family
ID=10862624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60042598T Expired - Lifetime DE60042598D1 (de) | 1999-10-12 | 2000-10-12 | Medikamente zur behandlung des syndroms der chronishen ermüdung, das mit fibromyalgie und reizdarm assoziert ist. |
Country Status (15)
Country | Link |
---|---|
US (1) | US6441038B1 (de) |
EP (1) | EP1220689B1 (de) |
AU (1) | AU782656B2 (de) |
CA (1) | CA2388377C (de) |
CZ (1) | CZ20021197A3 (de) |
DE (1) | DE60042598D1 (de) |
GB (1) | GB2355191A (de) |
HR (1) | HRP20020309A2 (de) |
HU (1) | HUP0203470A3 (de) |
MX (1) | MXPA02003724A (de) |
NO (1) | NO20021716L (de) |
NZ (1) | NZ518306A (de) |
PL (1) | PL354975A1 (de) |
SK (1) | SK4672002A3 (de) |
WO (1) | WO2001026623A2 (de) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1459750T3 (da) | 1999-07-01 | 2005-08-15 | Pharmacia & Upjohn Co Llc | (S,S)-rebexetin til behandling af fibromyalgi og andre somatoforme lidelser |
GB0216027D0 (en) * | 2002-07-10 | 2002-08-21 | Arachnova Therapeutics Ltd | New therapeutic use |
US20040048874A1 (en) * | 2001-05-22 | 2004-03-11 | Bardsley Hazel Judith | New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine |
US6602911B2 (en) * | 2001-11-05 | 2003-08-05 | Cypress Bioscience, Inc. | Methods of treating fibromyalgia |
US6635675B2 (en) | 2001-11-05 | 2003-10-21 | Cypress Bioscience, Inc. | Method of treating chronic fatigue syndrome |
WO2003068211A1 (en) * | 2002-02-12 | 2003-08-21 | Cypress Bioscience, Inc. | Methods of treating attention deficit/hyperactivity disorder (adhd) |
US20030176773A1 (en) * | 2002-03-12 | 2003-09-18 | Gendreau Roger Michael | Methods of assessing the level of a subjective symptom |
WO2003077897A1 (en) * | 2002-03-15 | 2003-09-25 | Cypress Bioscience, Inc. | Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes |
CA2483093A1 (en) * | 2002-04-24 | 2003-11-06 | Cypress Bioscience, Inc. | Use of milnacipran or a pharmaceutically acceptable salt thereof for treating chronic low back pain |
JP4545584B2 (ja) * | 2002-05-17 | 2010-09-15 | デューク ユニバーシティ | 肥満を治療するための方法 |
US20050215552A1 (en) * | 2002-05-17 | 2005-09-29 | Gadde Kishore M | Method for treating obesity |
TW200402289A (en) * | 2002-05-17 | 2004-02-16 | Wyeth Corp | Methods of treating gastrointestinary and genitourinary pain disorders |
WO2004016261A1 (en) * | 2002-08-12 | 2004-02-26 | Yuuichi Murayama | Method for suppressing proliferation of abnormal prion protein with leucine, isoleucine or valine |
JP2006504795A (ja) * | 2002-10-03 | 2006-02-09 | サイプレス バイオサイエンス, インコーポレイテッド | 神経学的障害を処置するための抗うつ剤の投薬量の段階的な漸増ならびに毎日の分割した投薬 |
US7704527B2 (en) * | 2002-10-25 | 2010-04-27 | Collegium Pharmaceutical, Inc. | Modified release compositions of milnacipran |
JP2006508978A (ja) * | 2002-11-19 | 2006-03-16 | イーライ・リリー・アンド・カンパニー | デュロキセチンを用いる胃腸障害の処置 |
KR20050111318A (ko) * | 2003-01-13 | 2005-11-24 | 다이노젠 파마세우티컬스, 인코포레이티드 | 기능성 장 질환을 치료하는 방법 |
EP1567163B1 (de) * | 2003-01-13 | 2007-04-11 | Dynogen Pharmaceuticals Inc. | Verfahren zur behandlung von übelkeit, erbrechen, würgereiz oder jede kombination daraus |
PT1601349E (pt) | 2003-02-14 | 2008-10-27 | Pf Medicament | Utilização do enantiómero (1s, 2r) do milnaciprano para a preparação de um medicamento |
FR2851163B1 (fr) | 2003-02-14 | 2007-04-27 | Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament | |
AU2004227945B2 (en) | 2003-04-04 | 2006-10-26 | Dynogen Pharmaceuticals, Inc. | Method of treating lower urinary tract disorders |
MXPA05011557A (es) | 2003-04-29 | 2006-03-09 | Orexigen Therapeutics Inc | Composiciones para afectar perdida de peso. |
WO2004105690A2 (en) * | 2003-05-23 | 2004-12-09 | Cypress Bioscience, Inc. | Treatment of chronic pain associated with drug or radiation therapy |
GB0313630D0 (en) * | 2003-06-12 | 2003-07-16 | Wwk Trust The | Compositions for the enhanced treatment of depression |
US7442372B2 (en) | 2003-08-29 | 2008-10-28 | Biomarin Pharmaceutical Inc. | Delivery of therapeutic compounds to the brain and other tissues |
CA2545584C (en) | 2003-11-17 | 2012-10-23 | Biomarin Pharmaceutical Inc. | Methods and compositions for the treatment of metabolic disorders |
US7713959B2 (en) * | 2004-01-13 | 2010-05-11 | Duke University | Compositions of an anticonvulsant and mirtazapine to prevent weight gain |
US20060160750A1 (en) * | 2004-01-13 | 2006-07-20 | Krishnan K R R | Compositions of an anticonvulsant and an antipsychotic drug and methods of using the same for affecting weight loss |
KR20060128995A (ko) | 2004-01-13 | 2006-12-14 | 듀크 유니버시티 | 체중감량에 영향을 미치는 항경련제와 항정신병 약물의조성물 |
WO2005107806A1 (en) * | 2004-04-21 | 2005-11-17 | Orexigen Therapeutics, Inc. | Compositions for affecting weight loss |
CA2576505A1 (en) * | 2004-08-03 | 2006-02-16 | Orexigen Therapeutics, Inc. | Combination of bupropion and a second compound for affecting weight loss |
US20080261955A1 (en) * | 2004-10-01 | 2008-10-23 | Timothy Dinan | Use of Pharmaceutical Compositions of Lofepramine for the Treatment of Adhd, Cfs, Fm and Depression |
EP1845952A2 (de) | 2004-11-17 | 2007-10-24 | Biomarin Pharmaceutical Inc. | Stabile tablettenformulierung von tetrahydrobiopterin |
EP1819340A2 (de) * | 2004-12-08 | 2007-08-22 | Biomarin Pharmaceutical Inc. | Verfahren und zusammensetzungen zur behandlung von lungenhypertonie bei neugeborenen |
US20060293309A1 (en) * | 2005-03-28 | 2006-12-28 | Dynogen Pharmaceuticals, Inc. | Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors |
US7994220B2 (en) * | 2005-09-28 | 2011-08-09 | Cypress Bioscience, Inc. | Milnacipran for the long-term treatment of fibromyalgia syndrome |
EP2135603B1 (de) | 2005-11-22 | 2013-01-02 | Orexigen Therapeutics, Inc. | Zusammensetzungen und Verfahren zur Erhöhung der Insulinsensitivität |
WO2007089318A2 (en) * | 2005-11-23 | 2007-08-09 | Orexigen Therapeutics, Inc. | Compositions and methods for reducing food cravings |
AR058239A1 (es) * | 2005-11-28 | 2008-01-23 | Orexigen Therapeutics Inc | Metodos para tratar trastornos de ansiedad |
JP2009518415A (ja) * | 2005-12-05 | 2009-05-07 | バイオマリン ファーマシューティカル インコーポレイテッド | 疾患の処置のための方法および組成物 |
US20090306050A1 (en) * | 2006-02-03 | 2009-12-10 | Timothy Dinan | Treatment and prevention of depression with pain, depression secondary to pain, and of neuropathic pain |
US8916195B2 (en) | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
US20080119452A1 (en) | 2006-09-12 | 2008-05-22 | Dolle Roland E | Methods for enhancing cognitive function |
WO2008042773A2 (en) * | 2006-09-29 | 2008-04-10 | Pdxrx, Inc. | Unitary pharmaceutical composition, method, and kit for the treatment or prevention of metabolic or endocrine disorders |
MX2009004874A (es) | 2006-11-09 | 2009-06-16 | Orexigen Therapeutics Inc | Formulaciones farmaceuticas estratificadas que comprenden una capa intermediaria que se disuelve rapidamente. |
CN101573103A (zh) | 2006-11-09 | 2009-11-04 | 奥雷西根治疗公司 | 用于施用重量减轻药物的单位剂量包装和方法 |
US20100009997A1 (en) * | 2007-01-12 | 2010-01-14 | Biomarin Pharmaceutical Inc. | Method of treating a metabolic or neuropsychiarty disorder with a bh4 derivative prodrug |
KR20100016445A (ko) | 2007-04-11 | 2010-02-12 | 바이오마린 파머수티컬 인크. | 테트라하이드로바이오프테린 투여 방법, 관련 조성물 및 측정 방법 |
SI2792662T1 (sl) | 2007-05-01 | 2016-10-28 | Concert Pharmacuticals Inc. | Spojine morfinana |
CA2725930A1 (en) | 2008-05-30 | 2009-12-30 | Orexigen Therapeutics, Inc. | Methods for treating visceral fat conditions |
US20100069389A1 (en) * | 2008-09-06 | 2010-03-18 | Bionevia Pharmaceuticals, Inc. | Novel forms of reboxetine |
EP2397158B1 (de) * | 2008-10-30 | 2016-04-13 | Concert Pharmaceuticals, Inc. | Kombination von Morphinan-Verbindungen und Antidepressiva zur Behandlung von pseudobulbärem Affekt |
JP2013510176A (ja) | 2009-11-06 | 2013-03-21 | ピエール ファーブル メディカモン | (1s,2r)−2−(アミノメチル)−n,n−ジエチル−1−フェニルシクロプロパンカルボキサミドの新規結晶形態 |
CN102724878A (zh) | 2010-01-11 | 2012-10-10 | 奥雷西根治疗公司 | 在重度抑郁症患者中提供体重减轻疗法的方法 |
US20120289744A1 (en) | 2010-11-03 | 2012-11-15 | Arch Pharmalabs Limited | Process for preparing optically pure milnacipran and its pharmaceutically acceptable salts |
WO2012178014A1 (en) * | 2011-06-24 | 2012-12-27 | K-Pax Pharmaceuticals, Inc. | Compositions and methods for treatment of chronic fatigue |
US9216178B2 (en) | 2011-11-02 | 2015-12-22 | Biomarin Pharmaceutical Inc. | Dry blend formulation of tetrahydrobiopterin |
RU2493839C1 (ru) * | 2012-02-28 | 2013-09-27 | Федеральное бюджетное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека | Способ лечения синдрома хронической усталости |
RS60682B1 (sr) | 2012-06-06 | 2020-09-30 | Nalpropion Pharmaceuticals Llc | Kompozicija za upotrebu u postupku lečenja prekomerne težine i gojaznosti kod pacijenata sa visokim kardiovaskularnim rizikom |
US20190381056A1 (en) | 2018-06-17 | 2019-12-19 | Axsome Therapeutics, Inc. | Compositions for delivery of reboxetine |
US11020402B2 (en) | 2018-10-15 | 2021-06-01 | Axsome Therapeutics, Inc. | Use of reboxetine to treat narcolepsy |
US20200147093A1 (en) | 2018-10-15 | 2020-05-14 | Axsome Therapeutics, Inc. | Use of esreboxetine to treat nervous system disorders such as fibromyalgia |
WO2020160263A1 (en) * | 2019-01-30 | 2020-08-06 | Synlev Pharmaceuticals Corporation | Formulations and methods for treatment of fibromyalgia and related myofascial pain disorders |
US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4431670A (en) * | 1980-12-19 | 1984-02-14 | Bernardo Heller | D-Phenylalanine treatment |
US4843071A (en) * | 1986-12-05 | 1989-06-27 | Serotonin Industries Of Charleston | Method and composition for treating obesity, drug abuse, and narcolepsy |
EP0784476B1 (de) * | 1994-10-05 | 2002-11-06 | Cari Loder | Behandlung von multipler sklerose (ms) und anderen demyelinisationserkrankungen unter verwendung von lofepramin in kombination mit l-phenylalamin, tyrosin oder tryptophan und evtl. einer vitamin b12-verbindung |
GB2297868B (en) | 1995-02-07 | 1999-04-28 | Nokia Mobile Phones Ltd | A shielding device |
JP3128609B2 (ja) | 1996-02-01 | 2001-01-29 | 株式会社小糸製作所 | 車輌用灯具の照射方向制御装置 |
US6335323B2 (en) * | 1996-07-05 | 2002-01-01 | The Wwk Trust | Compositions for the treatment of peripheral neuropathies containing antidepressants and/or monoamine oxidase inhibitors and/or vitamin B12 and/or precursors or inducers of a neurotransmitter |
US5765240A (en) * | 1996-07-31 | 1998-06-16 | L&P Property Management Co. | Spring bedding product collapsible in the transverse direction, and method of making it |
GB9617990D0 (en) * | 1996-08-29 | 1996-10-09 | Scotia Holdings Plc | Treatment of pain |
GB9618341D0 (en) * | 1996-09-03 | 1996-10-16 | Scotia Holdings Plc | Method of treatment |
-
1999
- 1999-10-12 GB GB9924172A patent/GB2355191A/en not_active Withdrawn
-
2000
- 2000-10-12 NZ NZ518306A patent/NZ518306A/en not_active IP Right Cessation
- 2000-10-12 SK SK467-2002A patent/SK4672002A3/sk unknown
- 2000-10-12 DE DE60042598T patent/DE60042598D1/de not_active Expired - Lifetime
- 2000-10-12 CZ CZ20021197A patent/CZ20021197A3/cs unknown
- 2000-10-12 AU AU79328/00A patent/AU782656B2/en not_active Ceased
- 2000-10-12 EP EP00969670A patent/EP1220689B1/de not_active Expired - Lifetime
- 2000-10-12 MX MXPA02003724A patent/MXPA02003724A/es not_active Application Discontinuation
- 2000-10-12 US US09/686,629 patent/US6441038B1/en not_active Expired - Fee Related
- 2000-10-12 HU HU0203470A patent/HUP0203470A3/hu unknown
- 2000-10-12 CA CA2388377A patent/CA2388377C/en not_active Expired - Fee Related
- 2000-10-12 PL PL00354975A patent/PL354975A1/xx not_active Application Discontinuation
- 2000-10-12 WO PCT/GB2000/003926 patent/WO2001026623A2/en active IP Right Grant
-
2002
- 2002-04-10 HR HR20020309A patent/HRP20020309A2/hr not_active Application Discontinuation
- 2002-04-11 NO NO20021716A patent/NO20021716L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ518306A (en) | 2004-04-30 |
AU782656B2 (en) | 2005-08-18 |
AU7932800A (en) | 2001-04-23 |
HUP0203470A3 (en) | 2005-10-28 |
CA2388377A1 (en) | 2001-04-19 |
EP1220689A2 (de) | 2002-07-10 |
EP1220689B1 (de) | 2009-07-22 |
MXPA02003724A (es) | 2003-10-14 |
HRP20020309A2 (en) | 2004-02-29 |
WO2001026623A3 (en) | 2001-06-21 |
CA2388377C (en) | 2011-02-01 |
GB2355191A (en) | 2001-04-18 |
US6441038B1 (en) | 2002-08-27 |
CZ20021197A3 (cs) | 2002-09-11 |
HUP0203470A2 (hu) | 2003-02-28 |
SK4672002A3 (en) | 2002-09-10 |
WO2001026623A2 (en) | 2001-04-19 |
NO20021716D0 (no) | 2002-04-11 |
PL354975A1 (en) | 2004-03-22 |
GB9924172D0 (en) | 1999-12-15 |
NO20021716L (no) | 2002-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60042598D1 (de) | Medikamente zur behandlung des syndroms der chronishen ermüdung, das mit fibromyalgie und reizdarm assoziert ist. | |
ATE291438T1 (de) | Pharmazeutische zusammensetzung zur behandlung von akutem schmerz, chronischem schmerz und/oder neuropathischem schmerz und migräne | |
ATE364386T1 (de) | (s,s)-reboxetine zur behandlung von chronischen erschöpfungssyndrom | |
DE69534130D1 (de) | Verbindungen zur behandlung von erkrankungen,die mit des vasculogenese und/oder angiogenese in verbunden stehen. | |
DE60109044D1 (de) | Arzneimittel zur behandlung der mucositis, stomatitis und des behcetschen syndroms | |
EE200300212A (et) | Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks | |
DE69916686D1 (de) | Gerät zur Behandlung von Atemstillstand im Schlaf | |
DE69940131D1 (de) | Mittel zur Behandlung von Erkrankungen der Speiseröhre | |
DE69929996D1 (de) | Pharmazeutisches mittel zur behandlung von diabetes | |
DE60113496D1 (de) | Verwendung von Glycyrrhizin zur Behandlung von Mastitis. | |
ATE542801T1 (de) | Zur behandlung von neoplastischen krankheiten, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4-pyrimidindiamine | |
DE60115872D1 (de) | Cabergolin zur behandlung von fibromyalgie und chronic-fatigue-syndrom | |
DE60108080D1 (de) | Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen | |
ATE306481T1 (de) | Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen | |
ATE253376T1 (de) | Polynukleotid-impfstoff, vorzugsweise zur behandlung der atemkrankheit bei rindern | |
DE58905201D1 (de) | Mittel zur behandlung des parkinson-syndroms. | |
BR0202519B1 (pt) | métodos para tratamento de material de madeira e para tratamento microbicida de material de madeira. | |
NO20052009D0 (no) | Kombinasjonsterapi for behandling av akutt leukumi og myelodysplastikksyndrom | |
DE60132851D1 (de) | Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension | |
EE9900118A (et) | H+,K+-ATPaasi inhibiitorite kasutamine ninapolüüpide ravimisel | |
RS50148B (sr) | Upotreba docetaksela za lečenje hepatoćelijskog karcinoma | |
EE05211B1 (et) | Saredutandi ja selle farmatseutiliselt vastuv?etavate soolade kasutamine meeleoluhirete, kohanemishirete v?i segatpi rev-depressiivsete hirete raviks v?i vltimiseks kasulike ravimite valmistamiseks | |
DE69327812D1 (de) | Arsen-enthaltende arzneimittel zur behandlung des chronischen ermüdungssyndroms | |
ATE359808T1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
ATE288279T1 (de) | Arzneimittel zur vermeidung oder behandlung von papillomavirus-spezifischem tumor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |